Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday morning, amid a frenzied rush to match booming consumer demand for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback